Mohammed Afshar

Keine laufenden Positionen mehr

Health Technology

Consumer Services

Profil

Mohammed Afshar is the founder.
Dr. Afshar was the founder of Ariana Pharmaceuticals SA, serving as Chief Executive Officer & Director since 2003.
Dr. Afshar is also the founder of RiboTargets Ltd. Former job at The University of York as Research Fellow.
Former job at Génomic Vision SA as Member-Supervisory Board.
Education at Université de Montpellier with undergraduate, graduate, and doctorate degrees.

Ehemalige bekannte Positionen von Mohammed Afshar

Unternehmen	Position	Ende
Ariana Pharmaceuticals SA Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Provides pharmaceutical, clinical and data technology	Gründer	08.08.2024
GENOMIC VISION	Direktor/Vorstandsmitglied	-
The University of York The University of York Other Consumer ServicesConsumer Services Functions as a College/University	Technik-/Wissenschafts-/F&E-Leiter	-
RiboTargets Ltd. RiboTargets Ltd. Pharmaceuticals: OtherHealth Technology Pharmaceutical research company	Gründer	-

Sehen Sie sich die Erfahrung von Mohammed Afshar im Detail an

Ausbildung von Mohammed Afshar

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Mohammed Afshar im Detail an

Unternehmensverbindungen

Private Unternehmen	5
RiboTargets Ltd. RiboTargets Ltd. Pharmaceuticals: OtherHealth Technology Pharmaceutical research company	Health Technology
Université de Montpellier Université de Montpellier Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of York The University of York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ariana Pharmaceuticals SA Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Provides pharmaceutical, clinical and data technology	Health Technology
Génomic Vision SA Génomic Vision SA Medical SpecialtiesHealth Technology Develops diagnostic tools using deoxyribonucleic acid analysis	Health Technology